Cancer Care Ontario | Cancer Care Ontario

3 Results

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Updated

Mar 2025

Guidelines and Advice

Status: Current
ID: GL 17-10 v2
Version: 2

Updated

Mar 2025

Guidelines and Advice

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025